Physician profile
Michael Gordon
NPI 1396728143
$2,338.22
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,736 · 2020: $226 · 2021: $336 · 2023: $20.71 · 2024: $19.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.86 | 2019-2021 | |
| Horizon Therapeutics Plc | $299.58 | 2019-2020 | |
| Ucb, INC. | $289.43 | 2019 | |
| Amgen INC. | $289.34 | 2019-2024 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $252.04 | 2019-2021 | |
| Pfizer INC. | $250.19 | 2019-2021 | |
| Lilly USA, LLC | $109.78 | 2019 | |
| Janssen Scientific Affairs, LLC | $86.91 | 2019 | |
| Janssen Biotech, INC. | $57.94 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $54.66 | 2019-2021 | |
| Genentech USA, INC. | $29.98 | 2019-2021 | |
| Celgene Corporation | $28.08 | 2019 | |
| Antares Pharma, INC. | $27.13 | 2019-2020 | |
| Glaxosmithkline, LLC. | $26.12 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $25.21 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $23.23 | 2019 | |
| Genzyme Corporation | $20.71 | 2023 | |
| Bioventus LLC | $17.72 | 2020 | |
| Radius Health, INC. | $17.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.16 | 2019 | |
| Assertio Therapeutics, INC. | $15.75 | 2019 | |
| Merck Sharp & Dohme LLC | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.